Regional Vice President - Southwest at HeartFlow

Denver, Colorado, United States

Apply Now

$345,000 – $405,000Compensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, HealthcareIndustries

Requirements

Sales leadership experience managing direct sales teams as well as coordinating support resources
Knowledge/experience developing and implementing go-to-market plans for new diagnostic or therapeutic areas in US markets
Experience solving customer needs and leveraging support resources to help innovate commercial offerings & processes
Deep understanding of hospital and practice economics, radiology and cardiovascular disease and relationships with practitioners in your assigned market
Knowledge/experience (incomplete in JD, but implied as relevant)

Responsibilities

Field Leadership: Hire, train and manage the customer-facing field sales team to meet revenue and customer retention goals within the region
Go To Market strategy: Collaborate with Commercial Leadership to develop detailed plans for market-entry and penetration in your assigned geography
Market Forecasts: Develop volume/revenue forecasts for Heartflow products in your assigned region markets through participation and leadership in our forecasting roll-up calls. The forecasting activity will also require in-depth use of Salesforce.com applications and Miller Heiman sales strategy methodology
Voice of Customer and Market Research: Gather deep “voice of customer” input to guide product development and market strategy. The RVP will be expected to develop extremely deep relationships with key customers throughout the region
Coordination of Heartflow One Team go-to-market model: Bringing together the local teams across the markets covered to deliver valuable program starting and developing initiatives through coordination of multiple roles (district sales managers, business development, implementation management, clinical applications, solutions engineering, market access, and field billing specialists)
Lead go-to-market efforts to drive market adoption for Heartflow’s products in the assigned region, including conducting stakeholder analysis in diverse markets, and constructing a regional sales strategy tailored to each submarket in the region
Regularly develop volume and revenue forecasts for each market in concert with the Sr. Vice President of Sales, North America
Hold primary responsibility for acquiring and communicating stakeholder “voice of customer” feedback and needs as part of the Heartflow customer service goals
Hire and lead the team of Territory Sales Managers and Territory Account Managers
Drive coordination of the One Team support functions (customer success & market access) as Heartflow grows in our commercial footprint

Skills

Sales Strategy

Stakeholder Analysis

Revenue Forecasting

Team Leadership

Go-to-Market

Market Adoption

Voice of Customer

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free